In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point

Míriam Alkorta, María-José Giménez, Diego Vicente, L. Aguilar, Emilio Pérez‐Trallero

International Journal of Antimicrobial Agents · 2005 · 12 citations · 8 references

Concepts

References

8